Figure 1From: Rapid and persistent selection of the K103N mutation as a majority quasispecies in a HIV1-patient exposed to efavirenz for three weeks: a case report and review of the literature Human immunodeficiency virus viremia, CD4+ T-cell counts and therapy during follow-up (3TC Lamivudine, AZT Zidovudine, ATV Atazanavir, IDV Indinavir, EFV Efavirenz, TDF Tenofovir, FTC Emtricitabine, GRT Genotyping Resistance Testing).Back to article page